silenced fetal gamma gene eliminating function researchers able reactivate fetal hemoglobin production 40 percent adult blood cells necessary not need dramatic increase help patients orkin notes 15 percent fetal hemoglobin benefit step researchers design therapeutic strategies enhancing fetal hemoglobin production gene therapy day provide avenue blocking bone marrow red blood cells orkin says likely chemical screens help identify drugs able silence patients shurin cautions years development needed human trials drug challenge facing researchers notes important development explore effects deactivating body ability fight infections diseases hampering gene effects red blood cells difficult orkin shurin agree importance study transcends therapeutic potential work